Blinatumomab Redirects Donor Lymphocytes against CD19


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
09 Nov 2023
Historique:
received: 16 08 2023
revised: 27 10 2023
accepted: 02 11 2023
medline: 27 11 2023
pubmed: 25 11 2023
entrez: 25 11 2023
Statut: epublish

Résumé

Blinatumomab alone or with donor leukocyte infusions (DLI) has been used after allogeneic hematopoietic stem cell transplantation (HSCT) as a salvage therapy in relapsing patients with CD19

Identifiants

pubmed: 38003295
pii: ijms242216105
doi: 10.3390/ijms242216105
pmc: PMC10671266
pii:
doi:

Substances chimiques

blinatumomab 4FR53SIF3A

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Italian Association for Cancer Research
ID : 20456
Organisme : Ministero della Salute
ID : Piano nazionale complementare al PNRR-E.3 - Iniziativa LSH-TA

Références

Immunotherapy. 2019 Apr;11(5):373-378
pubmed: 30786841
Blood. 2023 Jul 13;142(2):146-157
pubmed: 37172203
Leukemia. 2011 Jan;25(1):181-4
pubmed: 20944674
Leukemia. 2003 May;17(5):900-9
pubmed: 12750704
Blood. 2007 Mar 15;109(6):2649-56
pubmed: 17095616
Blood. 2014 Jul 24;124(4):638-44
pubmed: 24923299
Ther Adv Hematol. 2021 Feb 23;12:2040620721994348
pubmed: 33747421
Blood. 2013 Jun 13;121(24):4955-62
pubmed: 23652802
Haematologica. 2014 Jul;99(7):1212-9
pubmed: 24727818
N Engl J Med. 2013 Apr 18;368(16):1509-1518
pubmed: 23527958
N Engl J Med. 2011 Aug 25;365(8):725-33
pubmed: 21830940
N Engl J Med. 2017 Mar 2;376(9):836-847
pubmed: 28249141
J Immunol. 2015 Jul 1;195(1):347-55
pubmed: 25994967
JAMA. 2021 Mar 2;325(9):833-842
pubmed: 33651090
Science. 2008 Aug 15;321(5891):974-7
pubmed: 18703743
Clin Case Rep. 2016 Jun 24;4(8):743-6
pubmed: 27525074
Bone Marrow Transplant. 2016 Sep;51(9):1253-5
pubmed: 27088374
J Clin Oncol. 2016 Dec 20;34(36):4381-4389
pubmed: 27998223
Clin Cancer Res. 2019 Jan 15;25(2):473-477
pubmed: 30254079
Biol Blood Marrow Transplant. 2019 Aug;25(8):1498-1504
pubmed: 31002989
Blood Adv. 2021 Mar 9;5(5):1199-1208
pubmed: 33646302
Lancet Oncol. 2015 Jan;16(1):57-66
pubmed: 25524800
Blood. 2018 Mar 8;131(10):1045-1052
pubmed: 29358181
Blood. 2022 Mar 24;139(12):1908-1919
pubmed: 34914826
Blood. 2011 Apr 7;117(14):3921-8
pubmed: 21292771
Bone Marrow Transplant. 2023 Jan;58(1):72-79
pubmed: 36261707
Blood. 2018 Apr 5;131(14):1522-1531
pubmed: 29358182

Auteurs

Antonella Mancusi (A)

Division of Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy.

Francesco Zorutti (F)

Division of Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy.

Loredana Ruggeri (L)

Division of Hematology and Clinical Immunology, Azienda Ospedaliera S. Maria Della Misericordia, 06132 Perugia, Italy.

Samanta Bonato (S)

Division of Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy.

Sara Tricarico (S)

Division of Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy.

Tiziana Zei (T)

Division of Hematology and Clinical Immunology, Azienda Ospedaliera S. Maria Della Misericordia, 06132 Perugia, Italy.

Roberta Iacucci Ostini (R)

Division of Hematology and Clinical Immunology, Azienda Ospedaliera S. Maria Della Misericordia, 06132 Perugia, Italy.

Valerio Viglione (V)

Division of Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy.

Rebecca Sembenico (R)

Division of Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy.

Sofia Sciabolacci (S)

Division of Hematology and Clinical Immunology, Azienda Ospedaliera S. Maria Della Misericordia, 06132 Perugia, Italy.

Valeria Cardinali (V)

Division of Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy.

Massimo Fabrizio Martelli (MF)

Division of Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy.

Cristina Mecucci (C)

Division of Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy.

Alessandra Carotti (A)

Division of Hematology and Clinical Immunology, Azienda Ospedaliera S. Maria Della Misericordia, 06132 Perugia, Italy.

Maria Paola Martelli (MP)

Division of Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy.

Andrea Velardi (A)

Division of Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy.

Antonio Pierini (A)

Division of Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH